DEA rule seeks to make e-prescriptions more appealing to providers

05/3/2010 | Government Health IT magazine

A new Drug Enforcement Agency rule set to take effect next month could spur health IT adoption among providers by eliminating the requirement that they still use a paper-based system for controlled substances. Under the new rule, they will be allowed to use e-prescriptions for controlled substances. "Physicians will adopt e-prescribing much more rapidly when there is a singular work flow -- whether it's Lipitor or Valium," said Dr. John Halamka, Beth Israel Deaconess Medical Center CIO and Health IT Standards Committee co-chairman.

View Full Article in:

Government Health IT magazine

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ